Identification of azabenzimidazoles as potent JAK1 selective inhibitors

https://doi.org/10.1016/j.bmcl.2015.11.031Get rights and content

Abstract

We have identified a class of azabenzimidazoles as potent and selective JAK1 inhibitors. Investigations into the SAR are presented along with the structural features required to achieve selectivity for JAK1 versus other JAK family members. An example from the series demonstrated highly selective inhibition of JAK1 versus JAK2 and JAK3, along with inhibition of pSTAT3 in vivo, enabling it to serve as a JAK1 selective tool compound to further probe the biology of JAK1 selective inhibitors.

Section snippets

Acknowledgments

The authors would like to thank Stephanos Ioannidis, Mei Su, Lynsie Almeida, Jennifer Pink, Tao Wang, and Hai-Jun Zhang for their early contributions to this work and to Jason Kettle for helpful suggestions.

References and notes (20)

  • W. Vainchenker et al.

    Semin. Cell Dev. Biol.

    (2008)
  • D.E. Levy et al.

    Nat. Rev. Mol. Cell Biol.

    (2002)
  • D. Bondi

    J. Phys. Chem.

    (1964)
    A. Li et al.

    Proteins Struct. Funct. Genet.

    (1998)
  • K. Yamaoka et al.

    Genome Biol.

    (2004)
  • C. Rakieh et al.

    Adv. Ther.

    (2013)
  • H. Becker et al.

    Recent Results Cancer Res. (Small Molecules in Oncology)

    (2014)
  • C.S. Tam et al.

    Expert Opin. Investig. Drugs

    (2013)
  • C.J. Menet et al.

    Future Med. Chem.

    (2015)
    C.J. Menet et al.

    Prog. Med. Chem.

    (2013)
    B.W. Dymock et al.

    Expert Opin. Ther. Pat.

    (2013)
    E. Derenzini et al.

    Expert Opin. Investig. Drugs

    (2013)
There are more references available in the full text version of this article.

Cited by (0)

View full text